|Home||Internet of Things||Aerospace||Apparel||Energy||Defense||Health Care||Logistics||Manufacturing||Retail|
IoT News Roundup, Part Two
Monnit launches Internet of Things partner program; Vypin, LRNI unveil wireless IoT badging system; Kimberly-Clark joins Georgia Tech's Internet of Things Research Center; Clinical Ink, Integron partner to streamline IoT-enabled clinical trials; EVRYTHNG integrates GS1 identifiers with IoT at industrial scale; HID Global shares IFSEC study revealing how trusted identities bridge gap between connected workers and smart buildings; Industrial IoT company Samsara raises $40 million in Series C growth financing.
Clinical Ink, Integron Partner to Streamline IoT-enabled Clinical Trials
Clinical Ink, the pioneering provider of eSource and patient engagement technologies, and Integron, a leading provider of managed services for the connected health and Internet of Things (IoT) industry, have partnered to extend Clinical Ink's mobile device and sensor deployment capabilities to engage and collect data from patients in clinical trials.
The life science industry is accelerating the adoption of mobile devices and IoT technology to simplify the patient experience while collecting increasingly sophisticated endpoint data. Incorporating mobile and IoT devices requires global expertise to handle unique geographic logistical challenges, variable connectivity options, and device security/support for patients and sites.
"More and more clinical trial sponsors want to leverage mobile devices to engage patients and capture study data anytime and anywhere," said Jonathan Andrus, chief operating officer, Clinical Ink. "SureSource Engage gives sponsors the option to deploy an integrated ePRO, patient engagement and IoT platform that integrates with multiple sensors in either a provisioned or a Bring-Your-Own-Device (BYOD) model. We partnered with Integron to leverage their experience managing devices and data throughout the world to ensure we can meet our customers' IoT provisioning demands for clinical trials, globally."
"The clinical trial space represents an important market for Integron," stated Bryan Lubel, president of Integron. "Our wireless and mobile device management (MDM) services, which enable secure and seamless data capture through connected devices and sensors, combined with the patient engagement and data access capabilities of Clinical Ink, are providing cost-effective, seamless delivery and technology management to deliver successful clinical trial engagements."
Integron and Clinical Ink will both be showcasing their capabilities at DIA 2017, June 18–22 in Chicago. Visit Integron in booth 2058 and Clinical Ink in booth 527 to learn more.
Login and post your comment!
Not a member?
Signup for an account now to access all of the features of RFIDJournal.com!
SEND IT YOUR WAY
RFID JOURNAL EVENTS
ASK THE EXPERTS
Simply enter a question for our experts.
|RFID Journal LIVE!||RFID in Health Care||LIVE! LatAm||LIVE! Brasil||LIVE! Europe||RFID Connect||Virtual Events||RFID Journal Awards||Webinars||Presentations|